Medication info

Ilyang Dapagliflozin 5 mg (Dapagliflozin Propanediol Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Ilyang Pharmaceutical Co., Ltd.
Appearance
Yellow circular film-coated tablet
Packaging
28 tablets/box [7 tablets/Alu-Alu*4], 28 tablets/bottle
Approval status
Active

MFDS item code 202200898 · Approved 2022.03.02

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience with diabetes drug therapy, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine is not recommended to improve glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of the day, with or without food. Swallow the tablet whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Ilyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • impaired blood sugar control
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This drug is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be administered alone or in combination with other medications. It is particularly indicated for patients with cardiovascular disease or risk factors who are not achieving adequate blood sugar control. This helps to effectively improve blood sugar control and reduce the risk of cardiovascular events. Therefore, it plays a crucial role in the management of diabetes and contributes to the improvement of the patient's health status.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience with diabetes drug therapy, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine is not recommended to improve glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of the day, with or without food. Swallow the tablet whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This drug should not be used in certain patients. In particular, it is contraindicated in patients who are allergic to the active ingredient or excipients, patients with type 1 diabetes, patients with diabetic ketoacidosis, and patients undergoing dialysis. Caution should be exercised when administering this drug to patients with low fluid volume or impaired kidney function. This drug may lower blood pressure or affect kidney function, so fluid status and kidney function should be carefully monitored before and during administration. The blood sugar control effect of this drug varies depending on kidney function. For patients with moderate to severe kidney impairment, the blood sugar control effect may decrease, and it is not recommended for patients with severely reduced kidney function. When using this drug, symptoms of genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, and diabetic ketoacidosis may occur, so symptoms should be carefully monitored. In particular, women or patients with a history of infections may experience genital infections more frequently. Ketoacidosis can occur even when blood sugar is not high, so if symptoms such as vomiting, abdominal pain, fatigue, or difficulty breathing occur, immediate consultation with a healthcare professional is necessary. This drug may interact with other medications; therefore, careful dose adjustments may be needed, especially when used in combination with diuretics, insulin, or sulfonylureas, to reduce the risk of hypoglycemia or dehydration. Pregnant or breastfeeding women should avoid using this drug, and treatment should be discontinued upon confirmation of pregnancy. For children, the safety and efficacy of dapagliflozin have not been established, and therefore it should not be used. In cases of overdose, there is no specific antidote, so it is important to receive appropriate treatment based on symptoms. Patients taking this drug should be aware of the risk of hypoglycemia and symptoms of infection, and consult a doctor immediately if abnormal symptoms occur. Additionally, this drug should be stored out of reach of children and preserved in its original container to maintain quality.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, decreased renal creatinine clearance early in treatment, dyslipidemia, elevated serum creatinine early in treatment, elevated blood urea, weight loss, rash, angioedema, ketoacidosis, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, sensory disturbances, cerebral infarction, nerve compression, urinary tract infection, sinusitis, diverticulitis, pelvic inflammatory disease, pneumonia, pulmonary tuberculosis, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like symptoms, breast lump, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, discomfort in the vulva, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcers, excessive sweating eczema, dyshidrotic eczema, eczema, hyperkeratosis, pigmentation of nails, skin lesions, urticaria, cold sweat, flank pain, fibromyalgia, discomfort in limbs, muscle cramps, musculoskeletal discomfort, osteopenia, muscle weakness, bruising, road traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, iliac fracture, laceration, ligament tear, limb injury, meniscus injury, skin abrasion, tendon rupture, thoracic vertebra fracture, tibial fracture, dental injury, dry eye, eye pain, retinal disorders, vision loss, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, nocturia, hallucinations, sleep disorders, insomnia, fatty liver, gallbladder polyp, tinnitus, anal-genital warts, adenoma, neuroma, unspecified pituitary neoplasm, male gonadal hypofunction, thyroid cyst, thyroid nodule, food allergy, polycythemia, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, somnolence, headache, nasopharyngitis, upper respiratory infection, chest discomfort, pain, peripheral edema, generalized edema, hunger, vaginal discharge, irregular menstruation, itching, arthralgia, musculoskeletal pain, limb pain, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, shortness of breath

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is susceptible to air and moisture; therefore, it should be stored in a tightly closed container. Maintaining the storage temperature between 1 to 30 degrees Celsius at room temperature is important.

Appearance and packaging

Appearance

Yellow circular film-coated tablet

Package unit

28 tablets/box [7 tablets/Alu-Alu*4], 28 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.